Vertex Pharmaceuticals (VRTX) Competitors $391.02 -1.03 (-0.26%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$393.94 +2.92 (+0.75%) As of 08/29/2025 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock VRTX vs. AMZN, AXSM, CRSP, EDIT, GOOG, ISRG, MRNA, ABBV, LLY, and PFEShould you be buying Vertex Pharmaceuticals stock or one of its competitors? The main competitors of Vertex Pharmaceuticals include Amazon.com (AMZN), Axsome Therapeutics (AXSM), CRISPR Therapeutics (CRSP), Editas Medicine (EDIT), Alphabet (GOOG), Intuitive Surgical (ISRG), Moderna (MRNA), AbbVie (ABBV), Eli Lilly and Company (LLY), and Pfizer (PFE). Vertex Pharmaceuticals vs. Its Competitors Amazon.com Axsome Therapeutics CRISPR Therapeutics Editas Medicine Alphabet Intuitive Surgical Moderna AbbVie Eli Lilly and Company Pfizer Vertex Pharmaceuticals (NASDAQ:VRTX) and Amazon.com (NASDAQ:AMZN) are related large-cap companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, analyst recommendations, profitability and dividends. Do analysts rate VRTX or AMZN? Vertex Pharmaceuticals presently has a consensus target price of $497.10, suggesting a potential upside of 27.13%. Amazon.com has a consensus target price of $262.87, suggesting a potential upside of 14.79%. Given Vertex Pharmaceuticals' higher probable upside, equities research analysts clearly believe Vertex Pharmaceuticals is more favorable than Amazon.com.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vertex Pharmaceuticals 0 Sell rating(s) 13 Hold rating(s) 13 Buy rating(s) 1 Strong Buy rating(s) 2.56Amazon.com 0 Sell rating(s) 2 Hold rating(s) 46 Buy rating(s) 2 Strong Buy rating(s) 3.00 Does the media refer more to VRTX or AMZN? In the previous week, Amazon.com had 212 more articles in the media than Vertex Pharmaceuticals. MarketBeat recorded 242 mentions for Amazon.com and 30 mentions for Vertex Pharmaceuticals. Vertex Pharmaceuticals' average media sentiment score of 1.47 beat Amazon.com's score of 1.06 indicating that Vertex Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vertex Pharmaceuticals 25 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Amazon.com 180 Very Positive mention(s) 21 Positive mention(s) 17 Neutral mention(s) 14 Negative mention(s) 2 Very Negative mention(s) Positive Which has stronger valuation and earnings, VRTX or AMZN? Amazon.com has higher revenue and earnings than Vertex Pharmaceuticals. Vertex Pharmaceuticals is trading at a lower price-to-earnings ratio than Amazon.com, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVertex Pharmaceuticals$11.02B9.10-$535.60M$13.9927.95Amazon.com$637.96B3.83$59.25B$6.5634.91 Is VRTX or AMZN more profitable? Vertex Pharmaceuticals has a net margin of 31.86% compared to Amazon.com's net margin of 10.54%. Vertex Pharmaceuticals' return on equity of 23.91% beat Amazon.com's return on equity.Company Net Margins Return on Equity Return on Assets Vertex Pharmaceuticals31.86% 23.91% 17.14% Amazon.com 10.54%23.84%11.14% Which has more risk and volatility, VRTX or AMZN? Vertex Pharmaceuticals has a beta of 0.44, indicating that its share price is 56% less volatile than the S&P 500. Comparatively, Amazon.com has a beta of 1.31, indicating that its share price is 31% more volatile than the S&P 500. Do insiders and institutionals believe in VRTX or AMZN? 91.0% of Vertex Pharmaceuticals shares are held by institutional investors. Comparatively, 72.2% of Amazon.com shares are held by institutional investors. 0.2% of Vertex Pharmaceuticals shares are held by insiders. Comparatively, 9.7% of Amazon.com shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. SummaryAmazon.com beats Vertex Pharmaceuticals on 9 of the 17 factors compared between the two stocks. Get Vertex Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VRTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VRTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VRTX vs. The Competition Export to ExcelMetricVertex PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$100.52B$3.06B$5.66B$9.84BDividend YieldN/A2.28%3.93%4.04%P/E Ratio27.9520.9283.2726.61Price / Sales9.10200.54451.26176.28Price / CashN/A44.0537.7059.65Price / Book5.848.0710.556.59Net Income-$535.60M-$53.98M$3.27B$266.12M7 Day Performance-1.04%-0.88%0.42%0.17%1 Month Performance-16.66%6.20%5.91%3.02%1 Year Performance-21.15%7.13%48.11%19.69% Vertex Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VRTXVertex Pharmaceuticals4.9379 of 5 stars$391.02-0.3%$497.10+27.1%-20.7%$100.52B$11.02B27.956,100Positive NewsAMZNAmazon.com4.6354 of 5 stars$227.94-0.4%$262.87+15.3%+33.0%$2.43T$637.96B34.751,556,000Trending NewsAXSMAxsome Therapeutics4.7375 of 5 stars$116.31-1.9%$178.00+53.0%+36.1%$5.80B$495.03M-22.94380News CoveragePositive NewsInsider TradeCRSPCRISPR Therapeutics3.716 of 5 stars$54.13-0.3%$71.60+32.3%+9.0%$4.92B$35M-9.97460Trending NewsAnalyst UpgradeAnalyst RevisionEDITEditas Medicine4.1798 of 5 stars$2.72-2.9%$5.10+87.5%-30.7%$244.58M$38.90M-0.95230GOOGAlphabet4.4711 of 5 stars$209.16+1.2%$215.19+2.9%+30.7%$2.53T$371.40B22.27190,200Trending NewsISRGIntuitive Surgical4.9611 of 5 stars$468.44-1.6%$595.95+27.2%-2.8%$167.93B$8.35B65.3315,638Positive NewsMRNAModerna4.5835 of 5 stars$25.35-6.5%$42.88+69.2%-69.0%$9.86B$3.24B-3.375,800ABBVAbbVie4.7592 of 5 stars$207.58-1.4%$214.95+3.6%+7.7%$366.70B$58.33B98.8555,000Trending NewsLLYEli Lilly and Company5 of 5 stars$696.08-2.2%$950.17+36.5%-22.2%$658.81B$45.04B45.5047,000Trending NewsAnalyst UpgradeAnalyst RevisionPFEPfizer4.7832 of 5 stars$25.15-2.8%$28.12+11.8%-13.8%$142.99B$63.63B13.3881,000Positive News Related Companies and Tools Related Companies Amazon.com Alternatives Axsome Therapeutics Alternatives CRISPR Therapeutics Alternatives Editas Medicine Alternatives Alphabet Alternatives Intuitive Surgical Alternatives Moderna Alternatives AbbVie Alternatives Eli Lilly and Company Alternatives Pfizer Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VRTX) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMy NEXT $1 Trillion PredictionJames Altucher is making his next trillion-dollar prediction — and this time, it’s not Apple. He believes Elon...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vertex Pharmaceuticals Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Vertex Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VRTX Stock Alerts